Nocturnal hypoglycemia in children and adolescents with type 1 diabetes: Attempts at prediction and prevention

Endocrinologist

Volumn 9, Issue 5, 1999, Pages 342-349

  Kaufman, Francine Ratner ^a   Klein, Michelle ^a   Halvorson, Mary ^a   Pitukcheewanont, Pisit ^a   Fisher, Lynda K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN LISPRO;

CLINICAL FEATURE; DIETARY INTAKE; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN HYPOGLYCEMIA; INSULIN INFUSION; REVIEW; RISK FACTOR;

EID: 0032853481     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019616-199909000-00004     Document Type: Review

References (50)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus: The Diabetes Control and Complications Trial. N Engl J Med 1993; 329: 977-86.
2. The Diabetes Control and Complications Trial Research Group: The effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes: The Diabetes Control and Complications Trial. J Pediatr 1994; 125: 177-88.
3. Cryer PE: Hypoglycemia: the limiting factor in the management of IDDM. Diabetes 1994; 43: 1478-89.
4. The Diabetes Control and Complications Trial Research Group: Treatment-related adverse events in the DCCT: Diabetes Care 1995; 18: 1415-27.
5. The Diabetes Control and Complications Trial Research Group: Epidemiology of severe hypoglycemic in the Diabetes Control and Complications Trial (DCCT). Am J Med 1991; 90: 450-9.
6. Santiago J: Nocturnal hypoglycemic in children with diabetes: an important problem revisited. J Pediatr 1997; 131: 2-4.
7. American Diabetes Association: Medical Management of Insulin-Dependent Diabetes, Second Edition Ed. Alexandria, VA: JV Santiago 1994.
8. Cox DJ, Kovatchev BP, Julian DM, et al.: Frequency of severe hypoglycemia in insulin-dependent diabetes mellitus can be predicted from self-monitoring blood glucose data. J Clin Endocrinol Metab 1994; 79: 1659-62.
9. Beregszaszi M, Tubiana-Rufi N, Benali K, Noel M, Bloch J, Czernichow: Nocturnal hypoglycemia in children and adolescents with insulin-dependent diabetes mellitus: prevalence and risk factors. J Pediatr 1997; 131: 27-33.
10. Porter PA, Keating B, Byrne G, Jones TW: Incidence and predictive criteria of nocturnal hypoglycemia in young children with insulin-dependent diabetes mellitus. J Pediatr 1997; 130: 366-72.
11. Shalwitz RA, Farkas-Hirsch R, White N, Santiago JV: Prevalence and consequences of nocturnal hypoglycemia among conventionally treated children with diabetes mellitus. J Pediatr 1990; 116: 685-9.
12. Cryer PE: Hypoglycemia unawareness in IDDM. Diabetes Care 1993; 16: 40-7.
13. Kaufman FR: Diabetes in children and adolescents: areas of controversy. Med Clin N Am 1998; 82: 721-38.
14. Bhatia V, Wolfsdorf JI: Severe hypoglycemia in youth with insulin-dependent diabetes mellitus: frequency and causative factors. Pediatrics 1991; 88: 1187-93.
15. Daneman D, Frank M, Perlman K, Tamm J, Ehrlich R: Severe hypoglycemia in children with insulin-dependent diabetes mellitus: frequency and predisposing factors. J Pediatr 1989; 115: 681-5.
16. Nordfedlt S, Ludvigsson J: Severe hypoglycemia in children with IDDM: A prospective population study, 1992-1994. Diabetes Care 1997; 20: 497-503.
17. Kaufman F, Carpenter S, Mayer L, Halvorson M: Effect of a hypoglycemia prevention checklist in children with type 1 diabetes. Diabetes 1998; 47S: 1403A.
18. Pramming S, Thorsteinsson B, Bendtson I, Ronn B, Binder C: Nocturnal hypoglycemia in patients receiving conventional treatment with insulin. Br Med J 1985; 291: 376-9.
19. Anderson O, Sorensen M, Hougaard P, Mortensen HB: Nocturnal hypoglycemia in Danish children with type 1 diabetes mellitus: a nationwide study. Horm Res 1998; 50: 2A.
20. Brunelle RL, Llewelyn J, Anderson JH Jr, Gale EAM, Koivisto VA: Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes. Diabetes Care 1998; 21: 1726-31.
21. Howey DC, Bowsher RR, Brunelle R, Woodworth JR: [Lys(B28), Pro (B29)]-human insulin: a rapidly absorbed analogue of human insulin. Diabetes 1994; 43: 396-402.
22. Anderson JH Jr, Brunelle RL, Koivisto VA, et al.: Improved meal-time treatment of diabetes mellitus using insulin analogue. Clin Ther 1997; 19: 62-72.
23. Zinman B, Tildesley H, Chiasson J-L, Tsui E, Strack T: Insulin lispro in CSII: results of a double-blind crossover study. Diabetes 1997; 46: 440-3.
24. Pfutzner A, Kustner E, Forst T, et al.: Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes. Exp Clin Endocrinol 1996; 104: 25-30.
25. Anderson J, Brunelle RL, Koivisto VA, et al.: Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Diabetes 1997; 46: 265-70.
26. Ahmed AB, Home PD: The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients. Diabetes Care 1998; 21: 32-37.
27. Deeb LC, Brink SJ, Spencer M, Kidson H: Improved glycemic control using LisPro insulin before or after meals when compared to human regular insulin in prepubertal children. J Pediatr Endocrinol 1997; 11: 251.
28. Garg SK, Carmain JA, Braddy KC, et al.: Pre-meal insulin analogue insulin LisPro vs. Humulin insulin treatment in young subjects with type 1 diabetes. Diabetic Med 1996; 13: 47-52.
29. Holcombe J, Zalna S, Arora V, Headlee S, Gil A: Comparative study of insulin LisPro and regular insulin in 481 adolescents with type 1 diabetes. Diabetologia 1997; 46(Suppl. 1): 329A.
30. Gale E: Established clinical data on insulin lispro. Pract Diabetes Int Suppl 1997; 14: S2.
31. Tamborlane WV, Sherwin RS, Genel M, Felig P: Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 1979; 300: 573-8.
32. Olsson PO, Arnqvist H, von Schenck H, Ottoson AM: Overnight metabolic control with bedtime injection of intermediate-acting insulin or continuous subcutaneous insulin infusion. Diabetes Care 1987; 10: 702-5.
33. Hirsch IB, Farkas-Hirsch R, Cryer PE: CSII for the treatment of diabetic patients with hypoglycemia unawareness. Diab Nutr Metab 1991; 4: 41-3.
34. Koivisto VA, Yki-Jarvinen H, Helve E, Karonen SL, Pelkonen R: Pathogenesis and prevention of the dawn phenomenon in diabetic patients treated with CSII. Diabetes 1986; 35: 78-82.
35. Kuno T, Tasaki H, Miyazaki S: Continuous subcutaneous insulin injection for self-care of young patients with insulin-dependent diabetes mellitus. Acta Paediatr Jpn 1996; 38: 464-9.
36. Oesterle A, Boland E, Yu C, Tamborlane W, Grey M: CSII: a "new" way to achieve strict metabolic conrol and lower the risk of severe hypoglycemia in adolescents. Diabetes 1998; 47S: 1320A.
37. Schiffrin A, Belmonte M: Combined continuous subcutaneous insulin infusion and multiple subcutaneous injections in type 1 diabetic patients. Diabetes Care 1981; 4: 595-600.
38. Kanc K, Janssen MMJ, Keulen ETP, et al.: Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycemia in IDDM. Diabetologia 1998; 41: 322-9.
39. Launay B, Zinman B, Tildesley HD, Strack T, Chiasson J-L: Effect of Continuous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes. Diabetes Care 1998; 21: 1627-31.
40. Loghmani E, Rickard KA: Alternative snack system for children and teenagers with diabetes mellitus. J Am Dietetic Assoc 1994; 94: 1145-8.
41. Gray RO, Butler PC, Beers TR, Kryshak EJ, Rizza RA: Comparison of the ability of bread versus bread plus meat to treat and prevent subsequent hypoglycemic inpatients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996; 81: 1508-11.
42. Devgan S, Kaufman FR: Use of uncooked cornstarch to avert nocturnal hypoglycemia in patients with type 1 diabetes mellitus. Diabetes Suppl 1994; 43: 603A.
43. Kaufman FR, Devgan S: Use of uncooked cornstarch to avert nocturnal hypoglycemia in children and adolescents with type 1 diabetes. J Diabetes Compl 1996; 10: 84-7.
44. Ververs MTC, Rouwe C, Smit GPA: Complex carbohydrates in the prevention of nocturnal hypoglycemia in diabetic children. Eur J Clin Nutr 1993; 47: 268-73.
45. Wolfsdorf JI, Plotkin RA, Laffel LMB, Crigler JF Jr: Continuous glucose for treatment of patients with type 1 glycogen storage disease: comparison of the effects of dextrose and uncooked cornstarch on biochemical variables. Am J Clin Nutr 1990; 52: 1043-50.
46. Kaufman FR, Halvorson M, Kaufman ND: A randomized, blinded trial of uncooked cornstarch to diminish nocturnal hypoglycemia at diabetes camp. Diabetes Res Clin Pract 1995; 30: 205-9.
47. Kaufman FR, Halvorson M, Kaufman ND: Evaluation of a snack bar containing uncooked cornstarch in subjects with diabetes. Diabetes Res Clin Pract 1997; 35: 27-33.
48. Wiethop BV, Cryer PE: Glycemic actions of alanine and terbutaline in IDDM. Diabetes Care 1993; 16: 1124-30.
49. Wiethop BV, Cryer PE: Alanine and terbutaline in the treatment of hypoglycemia in IDDM. Diabetes Care 1993; 16: 1131-6.
50. Saleh TY, Cryer PE: Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM. Diabetes Care 1997; 20: 1231-6.